Skip to content

Effect of Nigella Sativa in Hypothyroidism

The Efficacy of Oral Consumption of Nigella Sativa with Placebo on Serum TSH in Patients with Hypothyroidism treated with Levothyroxine

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171113037424N2
Enrollment
42
Registered
2019-03-05
Start date
2018-03-21
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism. Hypothyroidism, unspecified

Interventions

Intervention 1: Intervention group: 2g/day of Nigella sativa powder equivalent to four capsules 250 mg and twice a day for 2 months plus levothyroxine tablets. Intervention 2: Control group: ?placebo

Sponsors

Shahed University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Hypothyroid patients who are diagnosed with endocrinologist and treated with levothyroxine for at least 2 consecutive visits with 10> TSH>2 age beween 16 and 65 years Patient's written consent form prior to participation in the study No history of heart disease, coagulation disorders, autoimmune disorders, pituitary and hypothalamic problems and kidney and malignant diseases, and other thyroid disorders such as Graves No Pregnancy or lactation

Exclusion criteria

Exclusion criteria: Taking any herbal drug that interferes with Nigella sativa

Design outcomes

Primary

MeasureTime frame
Thyroid-Stimulating Hormone (TSH). Timepoint: Before experiment and 2 months after experiment. Method of measurement: Laboratory_Thyroid-Stimulating Hormone(RIA assesment ).

Secondary

MeasureTime frame
Thyroid Questionnaire Score. Timepoint: before experiment and after 2month. Method of measurement: Zulewski's clinical score for hypothyroidism.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Fatemi Tekieh

Shahed University

dr.fatemi78@gmail.com+98 21 0215 1210

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026